New oral anticoagulants-TURKey (NOAC-TURK): Multicenter cross-sectional study


Altay S. , Yildirimturk O., Cakmak H. A. , Askin L., Sinan U. Y. , Besli F., ...Daha Fazla

ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.17, ss.353-361, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 17 Konu: 5
  • Basım Tarihi: 2017
  • Doi Numarası: 10.14744/anatoljcardiol.2016.7472
  • Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Sayfa Sayıları: ss.353-361

Özet

Objective: New oral anticoagulants (NOACs) are increasingly used both for prevention of stroke in non-valvular atrial fibrillation (NVAF) and the treatment of venous thromboembolism (VTE). In this study, we aimed to evaluate the current patterns of NOACs treatment in Turkey. Moreover, demographic and clinical parameters and bleeding and/or embolic events under NOACs treatment were analyzed.